step up trial semaglutide 7.2mg achieved 20.7% weight loss in obesity Safety and Pharmacokinetics of Single

In December 2025, the FDA approved a daily pill version of Wegovy, giving needle-averse patients the first oral GLP-1 option cleared for obesity treatment

The body circadian rhythm consolidates around the restored melatonin production

The latest data in the Ozempic and GLP-1 Consumer Tracker underscores the most up-to-date information on awareness, usage, and lifestyle changes, as well as the potential ramifications on prescription access, dietary changes, and retail

Expert Recommendations for Optimal Hydration Medical experts and major health organizations have developed specific hydration guidelines for patients taking GLP-1 medications , recognizing the unique challenges these drugs present

For cellular renewal and collagen synthesis, GHK-Cu